R
Rasmata Ouédraogo
Researcher at University of Ouagadougou
Publications - 36
Citations - 688
Rasmata Ouédraogo is an academic researcher from University of Ouagadougou. The author has contributed to research in topics: Neisseria meningitidis & MenAfriVac. The author has an hindex of 11, co-authored 35 publications receiving 615 citations.
Papers
More filters
Journal ArticleDOI
Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
Paul A. Kristiansen,Fabien Diomandé,Absatou Ky Ba,Idrissa Sanou,Abdoul Salam Ouedraogo,Rasmata Ouédraogo,Lassana Sangaré,Denis Kandolo,Flavien Aké,Inger Marie Saga,Thomas A. Clark,Lara K. Misegades,Stacey W. Martin,Jennifer Dolan Thomas,Sylvestre R. M. Tiendrebéogo,Musa Hassan-King,Mamoudou Harouna Djingarey,Nancy E. Messonnier,Marie-Pierre Préziosi,F. Marc LaForce,Dominique A. Caugant,Dominique A. Caugant +21 more
TL;DR: The disappearance of NmA carriage among both vaccinated and unvaccinated populations is consistent with a vaccine-induced herd immunity effect.
Journal ArticleDOI
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
Paul A. Kristiansen,Fabien Diomandé,Stanley C. Wei,Rasmata Ouédraogo,Lassana Sangaré,Idrissa Sanou,Denis Kandolo,Pascal Kaboré,Thomas A. Clark,Abdoul-Salam Ouédraogo,Ki Ba Absatou,Charles D. Ouédraogo,Musa Hassan-King,Jennifer Dolan Thomas,Cynthia Hatcher,Mamoudou Harouna Djingarey,Nancy E. Messonnier,Marie-Pierre Préziosi,Marc LaForce,Dominique A. Caugant,Dominique A. Caugant +20 more
TL;DR: The baseline carriage rate and serogroup distribution before vaccine introduction in the 1- to 29-year old population in Burkina Faso, the group chosen for the first introduction of the vaccine, forms a solid basis for evaluating the impact of MenAfriVac introduction on serogroups A carriage.
Journal ArticleDOI
Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.
Dominique A. Caugant,Dominique A. Caugant,Paul A. Kristiansen,Xin Wang,Leonard W. Mayer,Muhamed-Kheir Taha,Rasmata Ouédraogo,Denis Kandolo,Flabou Bougoudogo,Samba O. Sow,Laurence Bonte +10 more
TL;DR: In the seven years preceding introduction of a new serogroups A conjugate vaccine, serogroup A of the ST-5 clonal complex was identified as the predominant disease-causing strain.
Journal ArticleDOI
Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction.
Jeni Vuong,Jean-Marc Collard,Melissa J. Whaley,Issaka Bassira,Issaka Seidou,Seydou Diarra,Rasmata Ouédraogo,Dinanibè Kambiré,Thomas H. Taylor,Claudio Tavares Sacchi,Leonard W. Mayer,Xin Wang +11 more
TL;DR: Since the direct rt-PCR method does not require DNA extraction, it reduces the time and cost for processing CSF specimens, increases testing throughput, decreases the risk of cross-contamination, and conserves precious CSF.
Journal ArticleDOI
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
Paul A. Kristiansen,Absatou Ky Ba,Abdoul-Salam Ouédraogo,Idrissa Sanou,Rasmata Ouédraogo,Lassana Sangaré,Fabien Diomandé,Denis Kandolo,Inger Marie Saga,Lara K. Misegades,Thomas A. Clark,Marie-Pierre Préziosi,Dominique A. Caugant,Dominique A. Caugant +13 more
TL;DR: The significant reduction of NmA carriage still persisted two years following MenAfriVac vaccination, and no cases of Nm meningitis were recorded.